Physician profile
Logan Elliott
NPI 1730711029
$2,209.64
in general payments reported to CMS, 2019-2025
22 companies · $477 in 2025
The $477 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $459 · 2022: $638 · 2023: $503 · 2024: $132 · 2025: $477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $547.64 | 2023-2025 | Gemtesa |
| Astellas Pharma US INC | $327.33 | 2021-2023 | Myrbetriq |
| Urovant Sciences INC | $199.53 | 2022 | |
| Tolmar, INC. | $157.05 | 2023-2025 | Eligard, Jatenzo |
| Teleflex LLC | $133.58 | 2021-2025 | Barrigel, Urolift |
| Tolmar Pharmaceuticals, INC. | $106.01 | 2021-2022 | |
| Antares Pharma, INC. | $87.20 | 2021-2022 | |
| Boston Scientific Corporation | $78.23 | 2022-2025 | General - Female Sui, Rezum Generator |
| C. R. Bard, INC. & Subsidiaries | $66.89 | 2023-2025 | Bard Urinary Drainage Bag |
| Abbvie INC. | $64.80 | 2024-2025 | |
| Clarus Therapeutics INC. | $63.05 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.22 | 2021-2022 | |
| Rochester Medical Corporation | $47.79 | 2022 | |
| Progenics Pharmaceuticals, INC. | $46.95 | 2023 | Pylarify |
| Endo Pharmaceuticals INC. | $46.43 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $38.66 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $36.11 | 2022-2023 | Seglentis |
| Olympus America INC. | $28.39 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $26.53 | 2023 | Keytruda, Welireg, Lynparza |
| Pfizer INC. | $20.95 | 2024 | |
| Laborie Medical Technologies Corp. | $15.39 | 2025 | |
| Myovant Sciences INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Elliott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.